Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Glia ; 65(11): 1833-1847, 2017 11.
Article in English | MEDLINE | ID: mdl-28836295

ABSTRACT

Parkinson's disease (PD) symptoms do not become apparent until most dopaminergic neurons in the substantia nigra pars compacta (SNc) degenerate, suggesting that compensatory mechanisms play a role. Here, we investigated the compensatory involvement of activated microglia in the SN pars reticulata (SNr) and the globus pallidus (GP) in a 6-hydroxydopamine-induced rat hemiparkinsonism model. Activated microglia accumulated more markedly in the SNr than in the SNc in the model. The cells had enlarged somata and expressed phagocytic markers CD68 and NG2 proteoglycan in a limited region of the SNr, where synapsin I- and postsynaptic density 95-immunoreactivities were reduced. The activated microglia engulfed pre- and post-synaptic elements, including NMDA receptors into their phagosomes. Cells in the SNr and GP engulfed red fluorescent DiI that was injected into the subthalamic nucleus (STN) as an anterograde tracer. Rat primary microglia increased their phagocytic activities in response to glutamate, with increased expression of mRNA encoding phagocytosis-related factors. The synthetic glucocorticoid dexamethasone overcame the stimulating effect of glutamate. Subcutaneous single administration of dexamethasone to the PD model rats suppressed microglial activation in the SNr, resulting in aggravated motor dysfunctions, while expression of mRNA encoding glutamatergic, but not GABAergic, synaptic elements increased. These findings suggest that microglia in the SNr and GP become activated and selectively eliminate glutamatergic synapses from the STN in response to increased glutamatergic activity. Thus, microglia may be involved in a negative feedback loop in the indirect pathway of the basal ganglia to compensate for the loss of dopaminergic neurons in PD brains.


Subject(s)
Dopaminergic Neurons/pathology , Glutamic Acid/metabolism , Microglia/physiology , Parkinsonian Disorders/pathology , Subthalamic Nucleus/pathology , Synapses/pathology , Animals , Animals, Newborn , Cells, Cultured , Disease Models, Animal , Dopamine/genetics , Dopamine/metabolism , Exploratory Behavior/drug effects , Glutamic Acid/genetics , Male , Motor Activity/drug effects , Oxidopamine/toxicity , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/physiopathology , Phagocytosis/drug effects , Phagocytosis/physiology , Prosencephalon/cytology , Rats , Rats, Wistar , Subthalamic Nucleus/metabolism , Sympatholytics/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...